Nausea and vomiting are very common symptoms of early pregnancy and usually resolve by 16–20 weeks gestation (most commonly by 12 weeks). In most women these symptoms can be managed with simple diet and lifestyle advice and reassurance that it will not have an adverse effect on pregnancy. Women with more severe symptoms may require pharmacological treatment and, in some cases, referral to hospital for intravenous fluids and antiemetics.
         
        
        
	
		
		
			
			In this article 
  
		View / Download
		pdf version of this article
		
        
		
			
				| Key concepts | 
			
			
				
						- Nausea and vomiting are very common symptoms of early pregnancy and usually resolve by 12–20 weeks gestation
 
						- In most cases these symptoms can be managed with simple diet and lifestyle advice and reassurance that it will
							not have an adverse effect on pregnancy
 
						- Women with more severe symptoms may require treatment with medicines and, in severe cases, referral to hospital
							for intravenous fluids and antiemetics
 
					  | 
			
		
             
        
		Nausea and vomiting in early pregnancy is very common
		Nausea and vomiting in early pregnancy is so common that it can be considered a normal part of pregnancy. It is colloquially
			referred to as “morning sickness” although this is a misnomer because symptoms will often persist throughout
			the day. Up to 85% of women experience nausea in early pregnancy with approximately half of women vomiting as well. Symptoms
			usually begin between the fourth and seventh week after the last menstrual period and resolve in many women by the twelfth
			week and in most women by the twentieth week of pregnancy.1 A smaller number of pregnant women (approximately
			0.3–1%), have a more severe form of nausea and vomiting – hyperemesis gravidarum, which is characterised by persistent
			vomiting, weight loss of more than 5%, ketouria, electrolyte abnormalities (hypokalaemia) and dehydration.2
		While persistent nausea and vomiting in early pregnancy can be particularly debilitating for some women, it is not usually
			associated with any adverse pregnancy outcomes and in fact has been associated with lower rates of miscarriage.2 Hyperemesis
			gravidarum is on rare occasions associated with maternal complications such as Wernicke’s encephalopathy due to
			thiamine deficiency and foetal growth restriction.3
             
   
		Evaluation of nausea and vomiting in pregnancy
   
		Nausea and vomiting in pregnancy is usually a self-limiting condition, however, hyperemesis gravidarum should be distinguished
			from other conditions that may cause persistent vomiting, such as hepatitis, pancreatitis, pyelonephritis, peptic ulcer
			disease, thyroid disease and adrenocortical insufficiency. Investigations may include:4
		
			- Midstream urine microscopy to exclude a urinary tract infection 
 
			- Ultrasound to exclude trophoblastic disease or multiple pregnancy
 
			- TSH if there is suspicion of thyrotoxicosis
 
			- Electrolytes and liver function tests
 
		
		Nausea and vomiting that begins at or after 12 weeks gestation is unlikely to be caused by pregnancy so other causes
			should be investigated.3
		Rehydration may be required
		Women who present with mild to moderate dehydration can be managed with oral fluids. Women who are severely dehydrated
			will require referral to hospital for IV fluids and antiemetics, and in extreme cases nasogastric or parenteral nutrition.9 Alternatively,
			IV fluids and antiemetics may be given at the general practice clinic, if appropriate facilities are available.
		Normal saline (0.9%; 150 mmol/L) or Hartmann’s solution (sodium lactate) are appropriate choices for IV rehydration
			of pregnant women who are severely dehydrated. Dextrose containing fluids and hypertonic saline are inappropriate because
			they can precipitate severe neurological complications such as Wernicke’s encephalopathy and central pontine myelinolysis.3,10
        
       
		
			Aetiology and risk factors for nausea and vomiting in pregnancy
			The causes of nausea and vomiting in pregnancy are unknown, however, it is thought to be associated with rising levels
				of human chorionic gonadotropin (hCG). This is based on the observation that the incidence of hyperemesis is highest
				at the time where hCG production reaches its peak and that conditions associated with higher hCG levels (e.g twin and
				molar pregnancies) are also associated with higher rates of hyperemesis gravidarum. Oestrogen is another suggested cause
				with the presence of a female foetus reported to increase the likelihood of severe nausea and vomiting during pregnancy.4 One
				study found that women who were primiparous (first pregnancy), younger or were non-smokers were more likely to have nausea
				and vomiting in pregnancy.5 Another study found that 63% of multiparous women who had nausea and vomiting
				had also experienced it in a previous pregnancy.6 Chronic H. pylori infection has also been associated,
				in some studies, with nausea and vomiting in pregnancy.3
			There is some evidence that hyperemesis gravidarum is more common in Pacific women. One study in Wellington found that
				the incidence of hyperemesis gravidarum was significantly increased among Pacific women (particularly Samoan women) and
				was associated with thyroid function test abnormalities.7 Another study found that Pacific women were twice
				as likely to be hospitalised with hyperemesis gravidarum compared to other New Zealand women. The authors suggested that
				the higher prevalence of H. pylori in Pacific peoples could be a plausible explanation for the higher rates
				of hyperemesis gravidarum although they said psychosocial factors or thyroid function abnormalities could also be potential
				causes.8
		 
            
       
        
		Initial management in the majority of cases involves dietary and lifestyle advice
		While there is limited evidence from clinical trials about the effectiveness of dietary and lifestyle interventions,
			the following recommendations may be useful and should be trialled first:
            
		
			Dietary advice 4
			
				- Drink small amounts often – dehydration can exacerbate nausea so it is important for pregnant women to maintain hydration
					by drinking adequate fluids
 
				- Trial different kinds of fluids - sometimes fluids such as flat lemonade or diluted fruit juice are managed better
					than water 
 
				- Avoid fatty or spicy food – this may exacerbate symptoms
 
				- Avoid having an empty stomach – eat a light snack every one to two hours between meals
 
				- Avoid very large meals -– small amounts of food more often are usually better tolerated
 
				- Early morning nausea may be helped by eating a dry biscuit or cracker before getting out of bed
 
				- Salty food such as potato chips or salted crackers may help, especially before meals
 
			
		 
                 
            
		
			Lifestyle advice 4
			
				- Eat well when feeling the best or whenever feeling hungry
 
				- If the smell of hot food worsens nausea, try cold food instead, avoid cooking if possible or cook in well ventilated
					areas so that odours do not accumulate; ask for help from family and friends with cooking
 
				- Lie down when nauseated
 
				- Avoid stress
 
				- Take pregnancy vitamins (including folic acid) at a good time of the day (when feeling well) 
 
				- Keep physical activity gentle, getting too hot may exacerbate nausea
 
			
		 
        
            
		Alternative therapies – ginger, pyridoxine and acupressure
		Ginger has been shown in some studies to improve nausea and vomiting compared to placebo, however,
			there is conflicting data on the efficacy of ginger which may be the result of different preparations and potencies used
			in studies.3 The recommended dose of ginger is up to 1 g per day (in divided doses).11 Products
			which contain ginger such as tea, biscuits or confectionary may also be trialled. Ginger may cause reflux and heartburn
			in some people.1
		Pyridoxine (vitamin B6) is used first-line in many countries for nausea and vomiting in early pregnancy,
			however, there are large individual differences in its onset and action.3 Studies have shown that pyridoxine
			improves mild to moderate nausea but does not significantly reduce vomiting.12,13 The recommended dose in pregnant
			women is 25–50 mg, up to three times per day.11 Pyridoxine is available in 25 mg and 50 mg tablets, fully subsidised
			on the pharmaceutical schedule. Pyridoxine has been studied extensively as a combination product with doxylamine which
			was withdrawn from overseas markets, but has not proven to be associated with any teratogenic effects.12
		Acupressure involves stimulation, either manually or with elasticised bands, of the P6 Neiguan point
			which is found on the inside of the forearm three fingerbreadths above the wrist. There is some evidence that P6 acupressure
			reduces symptoms of nausea and vomiting but some studies, which included sham acupressure, have found a strong placebo
			effect.2
                 
            
		Manage other conditions such as heartburn
		Heartburn and reflux have been shown to exacerbate nausea and vomiting in pregnancy so managing these conditions, by
			making dietary changes or using medications, may help improve symptoms.12 Treatment with a H2 antagonist or
			a proton pump inhibitor will also protect against the effects of persistent vomiting.10 Omeprazole and ranitidine
			are considered safe to use during pregnancy.14
             
             
        
		Pharmacologic treatment may be appropriate for women continuing to experience intolerable nausea and vomiting
		Approximately 10% of women continue to experience significant nausea and vomiting during pregnancy, despite following
			dietary and lifestyle advice. In these cases, medications may be trialled.1 Antiemetics used in pregnancy include;
			metoclopramide, prochlorperazine cyclizine, promethazine and ondansetron. These medicines are listed in Table 1 in a suggested
			order in which to try them, however, individual patient factors and adverse effect profiles may alter this. For example,
			a more sedating antiemetic may be of benefit to some women but may be inappropriate in others, such as those with small
			children. Any antiemetic should be used at the lowest effect dose for the shortest time it is required.
   
            
		
			
				| Table 1: Antiemetics suitable for use in pregnancy (in order of preference)3,4,10 | 
			
			
				| Medication | 
				Dose | 
				Adverse effects | 
			
			
				| Metoclopramide | 
				10 mg three times daily  | 
				Extrapyramidal symptoms 
					Tardive dyskinesia especially if used for more than 12 weeks  | 
			
			
				| Prochlorperazine | 
				5 mg three times daily  | 
				Extrapyramidal symptoms 
					Sedation  | 
			
			
				| Cyclizine | 
				50 mg three times daily  | 
				Sedation | 
			
			
				| Promethazine | 
				25 mg at bedtime, increased to maximum 100 mg daily in divided doses | 
				Extrapyramidal symptoms 
					Sedation  | 
			
			
				| Ondansetron (hyperemesis gravidarum)  | 
				4 – 8 mg two to three times daily  | 
				Constipation
  | 
			
		
                 
            
		Metoclopramide is one of the most commonly prescribed medicines for nausea and vomiting.4 It
			has been found to be more effective than placebo in the treatment of hyperemesis gravidarum and has not been associated
			with any significant increase in risk of major congenital malformations or other adverse pregnancy outcomes.9,12 However,
			it is associated with drug-induced movement disorders and female gender is a risk factor for the development of this adverse
			effect.12
		Phenothiazines (e.g. prochlorperazine) reduce nausea and vomiting compared with placebo and studies have found no association
			with teratogenicity.2 Phenothiazines are more likely to cause drowsiness than the other antiemetics.3 Extrapyramidal
			effects and oculogyric crises are reported with phenothiazines as well as metoclopramide.3
		
For correspondence regarding the safety of prochlorperazine in pregnancy, see 
            "Correspondence: Prochlorperazine for nausea and vomiting in pregnancy", BPJ 41 (December, 2011).
		Antihistamines (e.g. cyclizine, promethazine) have been shown to significantly reduce nausea, however,
			they are associated with an increased risk of drowsiness. Studies have not found a significantly increased risk of teratogenicity
			with antihistamines.2 Meclozine (“Sea-legs”) was previously thought to be associated with cleft
			palate, however, recent studies have not shown an increased risk of malformation.12
                 
            
		Ondansetron may be considered in women with hyperemesis gravidarum 
		Ondansetron is an effective antiemetic which has been used in non-pregnant patients to treat nausea and vomiting. However,
			while animal data looks reassuring, there is very limited data on its safety in pregnant women.12 Common adverse
			effects include, fatigue, headaches and drowsiness. Constipation is also very common and can exacerbate symptoms of bloating
			and abdominal discomfort.10
                 
            
		Corticosteroids are usually limited to women with intractable nausea and vomiting
		Corticosteroids may be considered for women with intractable nausea and vomiting, but this is usually initiated in secondary
			care.3 While the mechanism of action is not well understood, some women experience a very rapid resolution
			of their symptoms when treated with corticosteroids.10 Oral corticosteroids have been associated with cleft
			palate when administered to pregnant women before ten weeks gestation so they are best avoided until after this time if
			possible.1
          		
 Best practice tip: Antiemetics can be taken according to when
			the pregnant woman experiences the most symptoms. For example, many women benefit from having a dose of antiemetic 30
			minutes before getting out of bed to prevent vomiting while having a shower or after having breakfast. Late afternoon
			symptoms associated with tiredness may be improved by a second dose around 1–2 pm.10
                 
             
		
			Acknowledgement
			Thank you to Dr Helen Paterson, Consultant in Obstetrics and Gynaecology, Senior Lecturer, Department
				of Women’s and Children’s Health, Dunedin School of Medicine, University of Otago for expert guidance in
				developing this article.
		 
		
		
			References
			
				- Niebyl JR. Nausea and vomiting in pregnancy. N Engl J Med 2010;363(16):1544-50.
 
				- National Institute for Health and Clinical Excellence (NICE). Antenatal care: routine care for the healthy pregnant
					woman. 2008. Available from: www.nice.org.uk (Accessed Oct, 2011).
 
				- Jarvis S. Management of nausea and vomiting in pregnancy. Br Med J 2011;342:d3606. 
 
				- Sheehan P. Hyperemesis gravidarum: assessment and management. Aust Fam Physician 2007;36(9):698-701.
 
				- Klebanoff MA, Koslowe PA, Kaslow R, Rhoads GG. Epidemiology of vomiting in early pregnancy. Obstet Gynecol 1985;66(5):612-6.
 
				- Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting in pregnancy. Br J Gen Pract 1993;43:245-8.
 
				- Jordan V, MacDonald J, Crichton S, et al. The incidence of hyperemesis gravidarum is increased among Pacific Islanders
					living in Wellington. N Z Med J 1995;108(1006):342-4.
 
				- Sopoaga F, Buckingham K, Paul C. Causes of excess hospitalisations among Pacific peoples in New Zealand: implications
					for primary care. J Primary Health Care 2010;2(2):105-10.
 
				- Quinlan JD, Hill DA. Nausea and vomiting of pregnancy. Am Fam Physician 2003;68(1):121-8.
 
				- Lowe S. Nausea and vomiting in pregnancy. O&G Magazine 2007;9(4).
 
				- Australian Medicines Handbook (AMH). Adelaide; AMH Pty Ltd, 2011.
 
				- Smith JA, Refuerzo JS, Ramin SM. Treatment of nausea and vomiting of pregnancy (hyperemesis gravidarum and morning
					sickness). UpToDate 2011. Available from: www.uptodate.com (Accessed Oct, 2011).
 
				- Festin M. Nausea and vomiting in early pregnancy. Clin Evid 2009;6:1405.
 
				- British National Formulary (BNF). BNF 62. London: BMJ Publishing Group and Royal Pharmaceutical Society of Great
					Britain, 2011.